ACI’s Paragraph IV Disputes Master Symposium – September 21-22, 2022 (Chicago)

August 5, 2022

Join members of the Judiciary and leading pharmaceutical patent litigators from brand name and generic drug companies at the American Conference Institute’s 8th Annual Paragraph IV Disputes Master Symposium taking place September 21-22, 2022, in Chicago!

As the industry prepares to address the fallout of global pharmaceutical patent losses of billions of dollars and the impact of evolving law, regulation and policy impacting the Hatch-Waxman landscape, the time for this conference has never been more relevant.

Ryan Daniel, Chief Patent Counsel from Fresenius Kabi USA, and 2022 Co-Chair says, “We’re excited to participate in ACI’s 8th Annual Paragraph IV Master Symposium, here in Chicago and in person for the first time in three years. It’s a very welcome opportunity to connect and engage with colleagues and the judiciary regarding the evolving landscape of Hatch-Waxman law and the pharmaceutical industry.”

Linda Friedlieb, Division Counsel from AbbVie, also 2022 Co-Chair adds, “The PIV conference attracts broad participation from key in-house and outside counsel, as well as the Patent Office and judges. It’s an excellent opportunity to cross-pollinate ideas and strategies.”

Along with this year’s 2022 co-chairs, join U.S. District Court Judges from District of Delaware, District of New Jersey, Eastern District of Pennsylvania, government representatives from key agencies, in-house counsel and law firms.

Register today (here) and save 10% with the FDA Law Blog promo code: D10-999-FDALAWBLOG.